🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/04/1982 | 1,98 | 1,99 | 1,97 | 1,99 | +0,17% | 1,00% | 2.350.454 |
| 08/04/1982 | 1,99 | 1,99 | 1,98 | 1,99 | +0,33% | 0,83% | 4.074.624 |
| 07/04/1982 | 1,99 | 2,00 | 1,98 | 1,98 | +0,00% | 1,17% | 2.705.098 |
| 06/04/1982 | 1,97 | 1,98 | 1,95 | 1,98 | +0,33% | 1,85% | 2.214.634 |
| 05/04/1982 | 1,98 | 1,98 | 1,97 | 1,97 | -0,33% | 0,50% | 1.912.810 |
| 02/04/1982 | 1,96 | 1,98 | 1,95 | 1,98 | +2,05% | 1,68% | 4.931.050 |
| 01/04/1982 | 1,93 | 1,94 | 1,91 | 1,94 | +1,56% | 1,55% | 3.297.427 |
| 31/03/1982 | 1,91 | 1,92 | 1,90 | 1,91 | +0,52% | 1,04% | 2.999.376 |
| 30/03/1982 | 1,90 | 1,91 | 1,88 | 1,90 | +0,17% | 1,57% | 3.531.341 |
| 29/03/1982 | 1,91 | 1,92 | 1,89 | 1,90 | -1,03% | 1,57% | 1.618.531 |
| 26/03/1982 | 1,93 | 1,94 | 1,92 | 1,92 | -2,20% | 1,37% | 2.222.179 |
| 25/03/1982 | 1,96 | 1,97 | 1,95 | 1,96 | -0,67% | 1,18% | 5.217.782 |
| 24/03/1982 | 1,98 | 1,99 | 1,97 | 1,97 | -0,33% | 1,01% | 2.806.963 |
| 23/03/1982 | 1,98 | 1,99 | 1,96 | 1,98 | +1,01% | 1,34% | 5.519.606 |
| 22/03/1982 | 1,95 | 1,97 | 1,93 | 1,96 | +1,54% | 2,21% | 5.006.506 |
| 19/03/1982 | 1,94 | 1,95 | 1,93 | 1,93 | -1,19% | 1,19% | 3.387.974 |
| 18/03/1982 | 1,93 | 1,95 | 1,91 | 1,95 | +2,61% | 2,57% | 7.141.910 |
| 17/03/1982 | 1,91 | 1,92 | 1,90 | 1,91 | +0,00% | 1,04% | 3.391.747 |
| 16/03/1982 | 1,92 | 1,93 | 1,90 | 1,91 | -0,52% | 1,38% | 4.451.904 |
| 15/03/1982 | 1,91 | 1,92 | 1,89 | 1,92 | +1,58% | 1,74% | 2.350.454 |
| 12/03/1982 | 1,88 | 1,89 | 1,87 | 1,89 | +0,18% | 1,41% | 6.655.219 |
| 11/03/1982 | 1,90 | 1,91 | 1,88 | 1,88 | -0,35% | 1,22% | 3.301.200 |
| 10/03/1982 | 1,91 | 1,93 | 1,89 | 1,89 | -2,06% | 2,43% | 5.885.568 |
| 09/03/1982 | 1,91 | 1,93 | 1,89 | 1,93 | +1,39% | 2,60% | 4.244.400 |
| 08/03/1982 | 1,92 | 1,94 | 1,89 | 1,90 | -0,35% | 2,42% | 4.617.907 |
| 05/03/1982 | 1,90 | 1,92 | 1,88 | 1,91 | +0,70% | 1,74% | 10.710.979 |
| 04/03/1982 | 1,91 | 1,92 | 1,89 | 1,90 | -2,22% | 1,56% | 11.714.544 |
| 03/03/1982 | 1,96 | 1,99 | 1,94 | 1,94 | -3,31% | 2,53% | 12.446.467 |
| 02/03/1982 | 2,04 | 2,07 | 2,00 | 2,00 | -2,42% | 3,58% | 8.647.258 |
| 01/03/1982 | 2,07 | 2,09 | 2,05 | 2,05 | -1,43% | 1,75% | 5.270.602 |